Umbilical cord serum magnesium level and neonatal outcome in group of neonates at 30-34 gestational age

• Autorzy: Gulczynska E , Zylinska L. , Kesiak M. , Grodzicka A. , Zjawiona A. , Cyranowicz B. , Krekora M. , Talar T. , Gadzinowski J.
• Języki publikacji: EN

Abstrakty

EN

Aim of study. To find correlation between the umbilical serum cord magnesium concentration in a group of newborns without antenatal exposition to magnesium sulphate and the neonatal outcome as well as to compare the neonatal outcome of babies with maternal magnesium sulphate treatment. Results. In a group of 82 newborns (31-34 GA; birth body weight <1500 g) the umbilical cord serum magnesium concentrations was assayed. Three subgroups of neonates were set apart: first group (N) with a normal magnesium level (n=28), the second group (n=19) with magnesium concentration <0.75 mmol/dl (D), and the third group (Mg) consisting of 35 newborn antenatally exposed to magnesium sulphate. These groups were similar (no statistical significances) in terms of birth body weight, gestational age, Apgar score and umbilical blood pH. Gradual decrease in magnesium concentration in relation to increase of gestational age was observed. In groups: D, N, Mg, gradual reduction of hospitalization time (p<0.05), risk of death, time of respiratory support, time of oxygen therapy, rate of bronchopulmonary dysplasia, periventricular leucomalation (p<0.05) were observed respectively. Likewise, a rate of serious neurological complication (IVH/ PVL) in group D was higher in comparison to groups N and Mg (although without statistical sig-nificances). Conclusion. Our results confirm that umbilical cord magnesium concentration in VLBW neonates have an influence on neonatal outcome. Although it is premature to recommend ordering maternal magnesium sulphate treatment to improve neonatal outcome, in our opinion the data presented here should at least induce magnesium concentration monitoring in pregnant women and magnesium deficiency correction.

Słowa kluczowe

EN

sulphate; magnesium level; neonatology; umbilical cord serum; neonate; newborn

• Wydawca: -
• Czasopismo: Journal of Elementology
• Rocznik: 2007
• Tom: 12
• Numer: 1
• Opis fizyczny: p.25-38,fig.,ref.

Twórcy

autor

Gulczynska E

• Polish Mother's Memorial Hospital-Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland

autor

Zylinska L.

autor

Kesiak M.

autor

Grodzicka A.

autor

Zjawiona A.

autor

Cyranowicz B.

autor

Krekora M.

autor

Talar T.

autor

Gadzinowski J.

Bibliografia

• Almonte R., Heath D., Whitehall J, Russell M., Patole S., Vink R. 1999. Gestational magnesium deficiency is deleterious to fetal outcome. Biol. Neonate., 76(1): 26-32.
• Buss I.H., Darlow B.A., Winterbourn C.C. 2000. Elevated protein carbonyls and lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants. Pediatr. Res., 47(5): 640-645.
• Caddell J., Graziani L., Wiswell T., Hsieh H., Mansmann H. 1999. The possible role of magnesium in protection of premature infants from neurological syndromes and visual impairments and a review of survival of magnesium-exposed premature infants. Magnes. Res., 12(3): 201-216.
• Caddell J. 1996. Evidence for magnesium deficiency in the pathogenesis of bronchopulmonary dysplasia (BPD). Magnes. Res., 9(3): 205-216.
• Caddell J. 1993. Hypothesis: possible links between the respiratory distress syndrome of the premature neonate, the sudden infant death syndrome, and magnesium deficiency shock. Magnes. Res., 6(1):25-32.
• Caddell J. 1995. Hypothesis: the possible role of magnesium and copper deficiency in retinopathy of prematurity. Magnes. Res., 8(3): 261-270.
• Chiu H., Chen C., Tsai S., Wu T., Yang C. 2005. Relationship between magnesium levels in drinking water and sudden infant death syndrome. Magnes. Res., 18(1): 12-18.
• Crowter C.A., Hiller J.E., Doyle L.W., Haslam R.R. 2003. Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. J.A.M.A., 290(20): 2669-2676.
• Crowther C., Doyle L. 2003. Magnesium sulphate prior to preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev.,(4).
• Deering S., Stagg A., Spong C., Abubakar K., Pezzullo J., Ghidini A. 2005. Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP). J. Matern. Fetal. Neonatal Med., 17(2): 151-155.
• Dickerson J., Widdowson E. 1960. Some effects of accelerating growth. II. Skeletal development. Proc. R. Soc. Lond. B. Biol. Sci., 17(152): 207-217.
• Di Renzo G.C., Mignosa M., Gerli S., Burnelli L., Luzi G., Clerici G., Taddei F., Marinelli D., Bragetti P., Mezzetti D., Della Torre B., Fanrauzzi A., Lungarotti M.S. 2005. The combined maternal administration of magnesium sulfate and aminophylline reduces intrvuentricular hemorrhage in very preterm neonates. Am. J. Obstet. Gynecol., 192(2): 433-438.
• Durlach J. 2004. New data on the importance of gestational Mg deficiency. J. Am. Coll. Nutr., 23(6): 694S-700S.
• Gomella T.L. 1992 . Neonatology. Management, procedures, on-call problems, diseases, drugs. 2nd ed. California. Appleton &Lange.
• Gulczyńska E., Gadzinowski J., Wilczyński J., Żylińska L. 2006. Prenatal MgSO4 treatment modifies the erythrocyte band 3 in preterm neonates. Pharmacol. Res., 53(4): 347-352.
• Gunther T., Ising H., Mohr-Nawroth F., Chahoud I., Merker H. 1981. Embryotoxic effects of magnesium deficiency and stress on rats and mice. Teratology, 24(2): 225-233.
• Harrison V., Peat G. 1997. Red blood cell magnesium and hypoxic-ischaemic encephalopathy. Early Hum. Dev., 47(3): 287-296.
• Hirtz D.G., Nelson K. 1998. Magnesium sulfate and cerebral palsy in premature infants. Curr. Opin. Pediatr., 10 (2): 131-137.
• Keeley M.M., Wade R.V., Laurent S.L., Hamann V.D. 1993. Alterations in maternal-fetal Doppler flow velocity waveforms in preterm labor patients undergoing magnesium sulfate tocolysis. Obstet. Gynecol., 81(2): 191-194.
• Kuban K.C., Leviton A., Pagano M., Fenton T., Styrassfeld R., Wolff M. 1992. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J. Child. Neurol., 7(1): 70-76.
• Marcus J.C., Valencia G.B., Altura B.T., Cracco Rq., Jean-Baptiste D., Sinha K., Altura B.M. 1998. Serum ionized magnesium in premature and term infants. Pediatr Neurol., 18(4): 311- -314.
• Mason B.A., Standley C.A., Whitty J.E., Cotton D.B. 1996. Fetal ionized magnesium levels parallel maternal levels during magnesium sulfate therapy for preeclampsia. Am. J. Obstet Gynecol., 175(1): 213-217.
• Murata Y., Itakura A., Matsuzawa K., Okumura A., Wakai K., Mizutani S. 2005. Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia. Brain Dev., 27(1):17-21.
• Nelson K., Grether J. 1995. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthwieght infants? Pediatrics, 95 (2): 263-269.
• Schauf B., Mannschreck B., Becker S., Dietz K., Wallwiener D., Aydeniz B. 2004. Evaluation of red blood cell deformability and uterine blood flow in pregnant women with preeclampsia or iugr and reduced uterine blood flow following the intrauenous application of magnesium. Hypertens. Pregnancy., 23(3): 331-343.
• Takaya J., Kaneko K. 2005. Fetus and magnesium. Clin. Calcium., 15(11): 105-110.
• Welty S.E. 2001. Is there a role for antioxidant therapy in bronchopulmonary dysplasia? J. Nutr., 131(3): 947S-950S.
• White D., Widdowson E., Woodard H., Dickerson J. 1991. The composition of body tissues (II). Fetus to young adult. Br. J. Radiol., 64(758): 149-159.
• Widdowson E., Dickerson J. 1962. Chemical composition of the body in mineral metabolism. Academic Press, New York, pp. 1-247.
• Zigliara J., Champetier M., Bonafos M., Lecannelier R., Lecleach G., Laliam B. 1971/1973. Lhypomagnesemie et les avortements spontanes. Int’l Symp. on Magnesium, 281-283.
• Zylinska L., Sobolewska B., Gulczyńska E., Ochedalski T., Soszyński M. 2002. Protein kinases activities in erythrocyte membranes of asphyxiated newborns. Clin. Biochem., 35(2): 93-98.